POSTER SESSION V
Wednesday, March 24, 2010   9:30 AM - 12:00 Noon
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GASTROINTESTINAL PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
51
Autoimmune-Associated Pouchitis: A Histologic Evaluation and Comparison to Antibiotic-Responsive Pouchitis and Normal Pouches
(660)
W Jiang, B Shen, JR Goldblum - Cleveland Clinic, Cleveland, OH
Digestive Lesions in Systemic Mastocytosis. A Study of 23 Patients
(613)
D Canioni, H Sokol, N Hoyeau, S Barete, F Soppelsa, P Dubreuil, O Lortholary, O Hermine - Hopital Necker, Paris, France; Hopital Saint Antoine, Paris, France; Hopital La Pitie Salpetriere, Paris, France; AFIRMM, Paris, France
Smoothelin Is a Specific Marker To Distinguish Muscularis Propria and Muscularis Mucosae in the Gastrointestinal Tract
(696)
MA Montani, T Thiesler, G Kristiansen - University Hospital Zurich, Zurich, Switzerland
Detection of Chromosomal Anomalies in Colon Biopsy Specimens Using Fluorescence In Situ Hybridization - A Pilot Study
(718)
J Qian, D Hossain, G Sadasivan, DG Bostwick - Bostwick Laboratories, Glen Allen, VA
Pathologic and Clinical Findings in over 10,000 Biopsies of the Terminal Ileum
(691)
SD Melton, MH Saboorian, RM Genta - Dallas VAMC - UT Southwestern Medical Center, Dallas, TX; Caris Diagnostics, Irving, TX
The Significance of Mucosal Eosinophilia in the Pediatric Colon
(636)
SM El Jamal, T Gibbons, E Davis, AG Saad - University of Arkansas for Medical Sciences, Little Rock, AR
Expression Profiling of Collagenous Colitis in Colonic Epithelium by Laser Capture Microdissection and PCR Array
(760)
BJ Winn, KT Sciandra, P Meitner, R Tavares, MB Resnick - Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI
Isolated Colitis Limited to the Peri-Appendiceal Orifice Related to Non-Steroidal Anti-Inflammatory Drugs
(629)
A Del Rio Perez, W Xin - University Hospitals Case Medical Center, Cleveland, OH
Atypical Histopathologic Features in Total Colectomy Specimens from Patients with Followup Proven Ulcerative Colitis
(651)
E Himmelfarb, O Chan, D Phan, D Dhall, P Fleshner, G Melmed, HL Wang - Cedars-Sinai Medical Center, Los Angeles, CA
Beta-Catenin Immunolabeling in Serrated Epithelial Change in the Setting of Inflammatory Bowel Disease
(661)
K Jockovic, EA Montgomery, CA Iacobuzio-Donahue - Johns Hopkins University, Baltimore, MD
Correlation between ATG16L1 and NOD2 Gene Crohn's Disease-Associated Risk Alleles with Abnormal Ileal Paneth Cell Morphology
(616)
W Cao, EC Boedecker, DN Frank, K Cadwell, L Mayer, TS Stappenbeck, RB Sartor, E Li, N Harpaz - Mt. Sinai School of Medicine, New York; U of Washington, St. Louis; U of Colorado, Denver; U of New Mexico, Albuquerque; U of N Carolina, Chapel Hill
Gastroesophageal Junction Hyperplastic (Inflammatory) Polyps: A Clinical and Pathologic Study of 46 Cases
(682)
KB Long, RD Odze - Brigham and Women's Hospital, Boston, MA
Prediction of Adenocarcinoma on Esophagectomy from Pre-Resection Biopsies of Barrett's Esophagus with at Least High Grade Dysplasia: A Comparison of Two Systems
(712)
DT Patil, JR Goldblum, T Plesec, A Bennett, W Henricks, L Schoenfield, L Yerian, MP Bronner, L Rybicki, T Rice, E Downs-Kelly - Cleveland Clinic, Cleveland, OH
Surface Epithelium Mitoses Are a Strong Predictor of Cancer Progression in Barrett's Esophagus
(622)
DP Coco, A Srivastava, CA Sanchez, DS Cowan, BJ Reid, PL Blount, RD Odze - Brigham & Women's Hospital, Boston; Dartmouth Hitchcock Medical Center, Lebanon; Fred Hutchinson Cancer Center & University of Washington, Seattle
Foveolar and Serrated Dysplasia Are Rare High-Risk Lesions in Barrett's Esophagus: A Prospective Outcome Analysis of 214 Patients
(742)
A Srivastava, CA Sanchez, DS Cowan, RD Odze - Dartmouth Hitchcock Medical Center, Lebanon; Fred Hutchinson Cancer Center & University of Washington, Seattle; Brigham & Women's Hospital, Boston
Risk of Conventional Dysplasia and Adenocarcinoma in Patients with Barrett's Esophagus and Crypt Dysplasia: A Prospective Follow-Up Study of 214 Patients
(743)
A Srivastava, DP Coco, CA Sanchez, DS Cowan, RD Odze - Dartmouth Hitchcock Medical Center, Lebanon; Brigham & Women's Hospital, Boston; Fred Hutchinson Cancer Center & University of Washington, Seattle
Interobserver Variability in the Diagnosis of Crypt Dysplasia in Barrett's Esophagus
(621)
D Coco, J Goldblum, J Hornick, GY Lauwers, E Montgomery, A Srivastava, H Wang, RD Odze - Brigham & Women's Hospital, Boston, MA; Cleveland Clinic, Cleveland, OH; Massachusetts General Hospital, Boston, MA; John Hopkins Hospital, Baltimore, MD; Dartmouth Medical Center, Lebanon, NH; Beth Israel Deaconess Medical Center, Boston, MA
Microsatellite Unstable Barrett's Esophagus-Associated Adenocarcinomas Are Rare, but Clinicopathologically Similar to the Colonic Counterpart
(630)
EG Demicco, AB Farris, AJ Iafrate, HA Gaissert, J Fukuoka, C Cohen, LR Zukerberg, GY Lauwers, M Mino-Kenudson - Massachusetts General Hospital, Boston; Emory University, Atlanta; Toyama Medical University, Toyama, Japan
"Clear Cell Change" in Colonic Tubular Adenoma and Corresponding Colonic Clear Cell Adenocarcinoma Is Associated with Decreased MUC2 and MUC5 Expression
(736)
C Shi, JR Scudiere, T Cornish, D Lam-Himlin, JY Park, E Montgomery - Johns Hopkins Hospital, Baltimore, MD; Caris Diagnostics, Boston
Validation of a Topographic-Anatomic Subclassification for Adencarcinoma of the GE Junction
(631)
EG Demicco, AB Farris, B Agbor-Etang, J Fukuoka, D Daives, M Snimizu, HA Gaissert, M Mino-Kenudson - Massachusetts General Hospital, Boston; Emory University, Atlanta; Toyama University Hospital, Toyama, Japan; Saitama Medical University, Saitama, Japan
Endoscopic Treatment Is Safe and Effective for High-Grade Dysplasia in Barrett's Esophagus
(624)
TC Cornish, D Lam-Himlin, JY Park, C Shi, E Montgomery - Johns Hopkins University, Baltimore, MD
Esophageal Leukoplakia: Risk Factors and Relationship to Squamous Neoplasia
(749)
MW Taggart, A Rashid, SC Abraham - MD Anderson Cancer Center, Houston, TX
Lack of ERCC1 and Olfactomedin 4 Protein Expression Predicts Neoadjuvant Therapy Sensitivity in GE Junction Adenocarcinoma
(625)
EL Courville, A Srivastava, TS Hong, OH Yilmaz, LN Calvo, BI Zaki, M Mino-Kenudson - Massachusetts General Hospital, Boston, MA; Dartmouth-Hitchcock Medical Center, Lebanon, NH
Histopathological Analysis of Glandular Lesions in Esophageal Endoscopic Mucosal Resections with Emphasis in Follow-Up Tissue Findings
(762)
S Yasir, MT Garcia, PA Bejarano - University of Miami/Jackson Memorial Hospital, Miami, FL
Stem Cell Markers CD44 and Nestin in Human Esophageal Adenocarcinoma and Its Precursor Lesions
(640)
W Feng, Z Zhou, D Tan - The University of Texas Medical School at Houston, Houston; University of Rochester Medical Center, Rochester; The University of Texas MD Anderson Cancer Center, Houston, TX
Bile Acid Reflux Contributes to the Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Via Activation of a Novel Bile Acid Receptor TGR5 and NADPH Oxidase NOX5-S
(614)
W Cao, J Hong, J Behar, J Wands, LJ Wang, RA DeLellis, D Lambeth, M Resnick - Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, RI; Emory University School of Medicine, Atlanta, GA
Esophageal Adenocarcinoma Shows Upregulation of Skp2 and Cks1 and Downregulation of p27
(681)
JY Liu, AM Bellizzi, IS Hatzaras, M Bloomston, WL Frankel - Ohio State University, Columbus, OH; Brigham and Women's Hospital, Boston, MA
Genetic Mutations in Dysplasia-Carcinoma Sequence Arising in a Background of Barrett's Esophagus - Does P53 Play a Role?
(752)
T Varma, ML Nordberg - Louisisna Health Sciences Center, Shreveport, LA; Feist-Weiller Cancer Center, Shreveport, LA
Expression of S100p in Human Esophageal Adenocarcinoma and Its Precursor Lesions
(639)
W Feng, Z Zhou, D Tan - The University of Texas Medical School at Houston, Houston; University of Rochester Medical Center, Rochester; The University of Texas MD Anderson Cancer Center, Houston, TX